Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.

Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS.

Ophthalmology. 2009 Dec;116(12):2286-93. doi: 10.1016/j.ophtha.2009.05.026. Epub 2009 Oct 7.

2.

Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.

Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Quigley HA.

Ophthalmology. 2009 Jun;116(6):1097-105. doi: 10.1016/j.ophtha.2009.01.021. Epub 2009 Apr 19.

PMID:
19376591
3.

Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.

Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS.

Ophthalmology. 2009 Feb;116(2):191-9. doi: 10.1016/j.ophtha.2008.09.004. Epub 2008 Dec 12.

PMID:
19084273
4.

Adherence improvement in Dutch glaucoma patients: a randomized controlled trial.

Beckers HJ, Webers CA, Busch MJ, Brink HM, Colen TP, Schouten JS; Dutch Adherence Study Group.

Acta Ophthalmol. 2013 Nov;91(7):610-8. doi: 10.1111/j.1755-3768.2012.02571.x. Epub 2012 Oct 1.

5.

Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.

Boland MV, Chang DS, Frazier T, Plyler R, Jefferys JL, Friedman DS.

JAMA Ophthalmol. 2014 Jul;132(7):845-50. doi: 10.1001/jamaophthalmol.2014.857.

PMID:
24831037
6.

Development and validation of a predictive model for nonadherence with once-daily glaucoma medications.

Chang DS, Friedman DS, Frazier T, Plyler R, Boland MV.

Ophthalmology. 2013 Jul;120(7):1396-402. doi: 10.1016/j.ophtha.2013.01.002. Epub 2013 Mar 28.

7.

Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.

Ford BA, Gooi M, Carlsson A, Crichton AC.

J Glaucoma. 2013 Jan;22(1):1-4. doi: 10.1097/IJG.0b013e31822e622f.

PMID:
21946541
8.

Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study).

Cate H, Bhattacharya D, Clark A, Fordham R, Holland R, Broadway DC.

BMC Ophthalmol. 2014 Mar 24;14:32. doi: 10.1186/1471-2415-14-32.

9.

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.

PMID:
17415690
10.

Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma.

Holló G, Kóthy P, Géczy A, Vargha P.

J Glaucoma. 2009 Apr-May;18(4):288-92. doi: 10.1097/IJG.0b013e31818456b9.

PMID:
19365193
12.

Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid.

Ajit RR, Fenerty CH, Henson DB.

Eye (Lond). 2010 Aug;24(8):1338-43. doi: 10.1038/eye.2010.27. Epub 2010 Mar 26.

PMID:
20339390
13.

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

Dubiner HB, Sircy MD, Landry T, Bergamini MV, Silver LH, Darell Turner F, Robertson S, Andrew RM, Weiner A, Przydryga J.

Clin Ther. 2004 Jan;26(1):84-91.

PMID:
14996520
14.

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.

Fellman RL, Sullivan EK, Ratliff M, Silver LH, Whitson JT, Turner FD, Weiner AL, Davis AA; Travoprost Study Group.

Ophthalmology. 2002 May;109(5):998-1008.

PMID:
11986110
15.
16.

Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.

Boland MV, Chang DS, Frazier T, Plyler R, Friedman DS.

JAMA Ophthalmol. 2014 Jul;132(7):838-44. doi: 10.1001/jamaophthalmol.2014.856.

PMID:
24830878
17.

Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination.

Rossi GC, Pasinetti GM, Scudeller L, Tinelli C, Milano G, Bianchi PE.

Expert Opin Pharmacother. 2010 Mar;11(4):499-504. doi: 10.1517/14656561003601994.

PMID:
20163264
18.

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.

Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK; International Travoprost Study Group.

J Glaucoma. 2001 Oct;10(5):414-22.

PMID:
11711841
19.

Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.

Toris CB, Zhan G, Fan S, Dickerson JE, Landry TA, Bergamini MV, Camras CB.

J Glaucoma. 2007 Mar;16(2):189-95.

PMID:
17473728
20.

A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.

Denis P, Andrew R, Wells D, Friren B.

Eur J Ophthalmol. 2006 May-Jun;16(3):407-15.

PMID:
16761242

Supplemental Content

Support Center